A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria

類似資料

• A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria
  著者:: Ekue, J. M. Kofi, 等
  出版事項: (1985)
• Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria; a double-blind trial for determining the most effective dose
  著者:: Harinasuta, T., 等
  出版事項: (1987)
• A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria
  著者:: Ekue, J. M. K., 等
  出版事項: (1987)
• Single-dose therapy of falciparum malaria with mefloquine or pyrimethamine—sulfadoxine
  著者:: Doberstyn, E. B., 等
  出版事項: (1979)
• Sequential treatment with quinine and mefloquine or quinine and pyrimethamine-sulfadoxine for falciparum malaria.
  著者:: Hall, A P, 等
  出版事項: (1977)